Targeting the androgen receptor pathway continues to have an important role in the treatment of CRPC, with abiraterone acetate and enzalutamide being the most exciting developments. Cabazitaxel is now considered the standard-of-care second-line chemotherapy for men with metastatic CRPC (mCRPC). Bone...
Testicular cancer; half the chemo dose works just as well Top ten compounds that fight cancer stem cells in prostate cancer Prostate cancer deaths hit record numbers in UK 2019 Research Off-label Fenbendazole programme for metastatic prostate cancer Immunotherapy may help only a small number of pros...
According to NCERT, the transformation of normal cells into cancerous neoplastic cells may be induced by physical, chemical, or biological agents. Cancer can be caused by: Oncogenic viruses Some viruses have cancer-causing genes that can induce the uncontrolled division of cells when they enter the...
Latest Conference Coverage Trastuzumab Combo Shows Numerical Survival Benefit in Gastric/GEJ Cancer Telotristat Ethyl Plus Chemo May Stabilize Weight in Metastatic PDAC Telephone Follow-Ups May Reduce AEs in Locally Advanced ESCC Evorpacept Demonstrates Efficacy in HER2-Positive Gastric/GEJ Cancer View ...
Metastatic prostate cancer is one of the leading causes of cancer death in men. Although Initialsly responsive to hormone therapy, it eventually progresses... AS Retter,WD Figg,WL Dahut - 《Clinical Prostate Cancer》 被引量: 30发表: 2003年 Chemotherapeutic inhibitors in the treatment of prostate...
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy Georges Gebrael Nicolas Sayegh Neeraj Agarwal Research31 Jan 2025Prostate Cancer and Prostatic Diseases P: 1-7 ...
4It stands as the primary cause of cancer-related mortality and poses a significant challenge in terms of diagnosis and treatment. Advancements in this domain have the potential to revolutionize the treatment paradigm. Gaining insights into the historical and current landscape of metastatic cancer can...
Find all the latest on breast cancer treatment at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
specific areas including risk stratification (12% vs 75%), imaging and staging (11% vs 80%), treatment (16% vs 81%), recurrence (15% vs 73%), castration-sensitive prostate cancer (9% vs 84%), castration-resistant prostate cancer (8% vs 73%), and metastatic bone disease (7% vs 84...